Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-11-19
DOI
https://doi.org/10.3389/fimmu.2025.1692336
Citations
2
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials

Jinhai Shen, Yuxuan Lin, Yonghe Liao
2 citations
Frontiers in Immunology
Esophageal Cancer Research and Treatment
4.01
article

Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials

Jinhai Shen, Yuxuan Lin, Yonghe Liao
article en
2 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Guangxi Medical University (CN), China Pharmaceutical University (CN), First Affiliated Hospital of GuangXi Medical University (CN)
Openalex Percentile: Top 6%
Esophageal Cancer Research and Treatment
4.01
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.